0 Promising results for Phase I live-attenuated Ebola vaccine
A live-attenuated Ebola vaccine has demonstrated promising results in a Phase I randomized controlled trial assessing safety and immunogenicity, according to a Canadian study.
Browsing: Emerging Disease
0 Function of Ebola delta peptide uncovered
Researchers investigating Ebola virus have uncovered the function of delta protein, which is released in high levels during infection, and findings suggest it could play a crucial role in disease pathology.
0 Novel imaging allows real-time monitoring of dengue infection in the body
Researchers have demonstrated an imaging technique utilizing PET, which allows non-invasive and real-time monitoring of dengue infection in mouse models.
0 ASM Microbe: NS1-based Zika vaccine demonstrates promise in mice
Research presented at ASM Microbe has reported a Zika vaccine based on the NS1 protein can induce protective immunity in mouse models after a single dose.
0 Structure uncovered for Lassa virus glycoprotein
Researchers have uncovered structural and functional details of a key Lassa virus protein; this new information may aid the development of vaccines and therapeutics in the future.
0 Assessing the epidemic threat of viruses – candidates for the next pandemic
Author, Mark Woolhouse, discusses recent efforts to identify pathogens with pandemic potential and his own work on emerging viruses.
0 Characterization of oligonucleotide aptamers targeting the 5′-UTR from dengue virus
In this preliminary communication, the authors selected and characterized aptamers targeting the 5′-UTR from dengue virus, a sequence with important regulatory elements for its life cycle, with applications as potential antiviral and diagnostic tools.
0 Novel retinal lesion identified in Ebola survivors
Researchers examining post-Ebola syndrome have discovered ocular consequences, including a disease-associated retinal scar.
0 The next pandemic – priorities for prevention
Editor, Martha Powell, takes a closer look at MERS, Nipah and Lassa; considering their impact on populations thus far and why medical countermeasures against them are so urgently required.
0 ECCMID17: Could Wolbachia be a promising tool to control Zika?
Research presented at ECCMID 2017 highlighted the potential of intracellular bacterium Wolbachia to control and prevent arboviruses, including Zika and chikungunya.